145 related articles for article (PubMed ID: 25430863)
41. A novel cell cycle blocker extracted from Stellera chamaejasme L. inhibits the proliferation of hepatocarcinoma cells.
Kan XX; Li Q; Chen X; Wang YJ; Li YJ; Yang Q; Xiao HB; Wang ZX; Chen Y; Weng XG; Cai WY; Zhu XX
Oncol Rep; 2016 Jun; 35(6):3480-8. PubMed ID: 27109908
[TBL] [Abstract][Full Text] [Related]
42. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
43. The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 up-regulation.
Androutsopoulos VP; Spandidos DA
J Nutr Biochem; 2013 Feb; 24(2):496-504. PubMed ID: 22749133
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of novel pyrazole derivatives with anticancer activity.
Balbi A; Anzaldi M; Macciò C; Aiello C; Mazzei M; Gangemi R; Castagnola P; Miele M; Rosano C; Viale M
Eur J Med Chem; 2011 Nov; 46(11):5293-309. PubMed ID: 21920636
[TBL] [Abstract][Full Text] [Related]
45. LRD-22, a novel dual dithiocarbamatic acid ester, inhibits Aurora-A kinase and induces apoptosis and cell cycle arrest in HepG2 cells.
Wang H; Li R; Li L; Ge Z; Zhou R; Li R
Biochem Biophys Res Commun; 2015 Feb; 458(1):201-7. PubMed ID: 25645017
[TBL] [Abstract][Full Text] [Related]
46. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
[TBL] [Abstract][Full Text] [Related]
47. [Effects of simvastatin on the proliferation of HepG2 cells].
Liu W; Zhang LF; Zhang YH
Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):751-3. PubMed ID: 21059291
[TBL] [Abstract][Full Text] [Related]
48. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway.
Hsu TS; Chen C; Lee PT; Chiu SJ; Liu HF; Tsai CC; Chao JI
Cancer Chemother Pharmacol; 2008 Oct; 62(5):799-808. PubMed ID: 18193228
[TBL] [Abstract][Full Text] [Related]
49. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
[TBL] [Abstract][Full Text] [Related]
50. COH-203, a novel microtubule inhibitor, exhibits potent anti-tumor activity via p53-dependent senescence in hepatocellular carcinoma.
Qi H; Zuo DY; Bai ZS; Xu JW; Li ZQ; Shen QR; Wang ZW; Zhang WG; Wu YL
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):262-8. PubMed ID: 25449279
[TBL] [Abstract][Full Text] [Related]
51. Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Novel Indolylacrylamide Derivatives: Synthesis and Biological Evaluation.
Hawash M; Kahraman DC; Cetin-Atalay R; Baytas SN
Chem Biodivers; 2021 May; 18(5):e2001037. PubMed ID: 33713038
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and biological evaluation of 4β-sulphonamido and 4β-[(4'-sulphonamido)benzamide]podophyllotoxins as DNA topoisomerase-IIα and apoptosis inducing agents.
Kamal A; Suresh P; Ramaiah MJ; Mallareddy A; Imthiajali S; Pushpavalli SN; Lavanya A; Pal-Bhadra M
Bioorg Med Chem; 2012 Mar; 20(6):2054-66. PubMed ID: 22364746
[TBL] [Abstract][Full Text] [Related]
53. Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells.
Sudan S; Rupasinghe HP
Anticancer Res; 2014 Apr; 34(4):1691-9. PubMed ID: 24692698
[TBL] [Abstract][Full Text] [Related]
54. Molecular mechanism of hepatocellular carcinoma-specific antitumor activity of the novel thienopyridine derivative TP58.
Zhou R; Huang WJ; Guo ZY; Li L; Zeng XR; Deng YQ; Hu FY; Tong AP; Yang L; Yang JL
Oncol Rep; 2012 Jul; 28(1):225-31. PubMed ID: 22552608
[TBL] [Abstract][Full Text] [Related]
55. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL
Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843
[TBL] [Abstract][Full Text] [Related]
56. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
[TBL] [Abstract][Full Text] [Related]
57. One-pot synthesis and antiproliferative activity of novel 2,4-diaminopyrimidine derivatives bearing piperidine and piperazine moieties.
Ma WF; Yang HK; Hu MJ; Li Q; Ma TZ; Zhou ZZ; Liu RY; You WW; Zhao PL
Eur J Med Chem; 2014 Sep; 84():127-34. PubMed ID: 25016234
[TBL] [Abstract][Full Text] [Related]
58. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.
Abreu RM; Ferreira IC; Calhelha RC; Lima RT; Vasconcelos MH; Adega F; Chaves R; Queiroz MJ
Eur J Med Chem; 2011 Dec; 46(12):5800-6. PubMed ID: 22014996
[TBL] [Abstract][Full Text] [Related]
59. 6-[(1-naphthylmethyl)sulfanyl]-9H-purine induces G2/M phase arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Yang XG; Bao YL; Huang YX; Sun LG; Zhang YW; Yu CL; Wu Y; Li YX
Eur J Pharmacol; 2012 Nov; 695(1-3):27-33. PubMed ID: 23000392
[TBL] [Abstract][Full Text] [Related]
60. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2.
Ou X; Lu Y; Liao L; Li D; Liu L; Liu H; Xu H
Oncol Rep; 2015 Mar; 33(3):1264-74. PubMed ID: 25530218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]